BNGO · Bionano Genomics, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Accordingly, based on recurring losses from operations incurred since inception, the expectation of continued operating losses, and the need to raise additional capital to finance our future operations, we determined that there is substantial doubt about our ability to continue as a going concern within 12 months after the date that the financial statements included in this Quarterly Report are issued.”View the 10-Q filed Aug 10, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-03 | Hastie Alex Reid |
Chief Scientific Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
25% of the shares subject to the option shall vest and become exercisable on August 2, 2027, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from August 2, 2027, subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each such applicable vesting date. The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. |
Stock Option (Right to Buy)
|
54,000 |
| 2026-08-03 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date. The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. |
Stock Option (Right to Buy)
|
15,000 |
| 2026-08-03 | Dixon Jonathan V. |
GENERAL COUNSEL |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date. The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. |
Stock Option (Right to Buy)
|
15,000 |
| 2026-08-03 | Adamchak Mark |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares subject to the option vest 50% of the total on each of the first and second anniversaries of the vesting commencement date, in each case subject to the Reporting Person's Continuous Service (as defined in the Company's 2018 Plan) through each applicable vesting date. The initial Form 3 filed on August 5, 2026 was erroneously filed. This Form 4 replaces the Form 3 filed. |
Stock Option (Right to Buy)
|
5,000 |
| 2026-06-03 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
27 |
| 2026-06-03 | Chaubey Alka |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
24 |
| 2026-06-03 | Adamchak Mark |
Principal Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2026 pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
7 |
| 2026-06-03 | Dixon Jonathan V. |
GENERAL COUNSEL |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2026, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
24 |
| 2026-05-14 | Linney Yvonne |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
9,149 |
| 2026-05-14 | TWOMEY CHRISTOPHER J |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
9,149 |
| 2026-05-14 | Vuori Kristiina MD |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
9,149 |
| 2026-05-14 | BARKER DAVID L |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
9,149 |
| 2026-05-14 | Rajkovic Aleksandar |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
9,149 |
| 2026-02-17 | Holmlin R. Erik |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
51 |
| 2026-02-17 | Adamchak Mark |
Principal Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 3 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
3 |
| 2026-02-17 | Dixon Jonathan V. |
GENERAL COUNSEL |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
6 |
| 2026-02-17 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
20 |
| 2026-02-17 | Chaubey Alka |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2026 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
18 |
| 2026-02-02 | Adamchak Mark |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% of the shares subject to the option vest on the one-year anniversary of the grant date. |
Stock Option (Right to Buy)
|
10,890 |
| 2026-02-02 | Dixon Jonathan V. |
GENERAL COUNSEL |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
26,117 |
| 2026-02-02 | Holmlin R. Erik |
Director, PRESIDENT AND CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
69,484 |
| 2026-02-02 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
27,737 |
| 2026-02-02 | Chaubey Alka |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
27,737 |
| 2025-09-11 | Chaubey Alka |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer an aggregate of 51 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
51 |
| 2025-09-11 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
59 |
| 2025-06-11 | Luderer Albert |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
2,775 |
| 2025-06-11 | Mamuszka Hannah |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
2,775 |
| 2025-06-11 | Rajkovic Aleksandar |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
2,775 |
| 2025-06-11 | TWOMEY CHRISTOPHER J |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
2,775 |
| 2025-06-11 | BARKER DAVID L |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
2,775 |
| 2025-06-11 | Linney Yvonne |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
2,775 |
| 2025-06-11 | Vuori Kristiina MD |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the option holder's Continuous Service (as defined in the Company's 2018 equity incentive plan) through each such vesting date and will vest in full upon a Change of Control (as defined in the Company's 2018 equity incentive plan). |
Stock Option (Right to Buy)
|
2,775 |
| 2025-06-03 | Dixon Jonathan V. |
GENERAL COUNSEL |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 25 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
25 |
| 2025-06-03 | Chaubey Alka |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 24 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
24 |
| 2025-06-03 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 27 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
27 |
| 2025-06-03 | Holmlin R. Erik |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 75 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
75 |
| 2025-06-03 | Adamchak Mark |
Principal Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 7 shares of common stock in connection with shares that vested on June 3, 2025, pursuant to an RSU award granted on June 3, 2024, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. |
Common Stock
|
7 |
| 2025-03-14 | Dixon Jonathan V. |
GENERAL COUNSEL |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
6,559 |
| 2025-03-14 | Holmlin R. Erik |
Director, PRESIDENT AND CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
17,449 |
| 2025-03-14 | Adamchak Mark |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% of the shares subject to the option vest on the one-year anniversary of the grant date. |
Stock Option (Right to Buy)
|
3,029 |
| 2025-03-14 | Chaubey Alka |
CHIEF MEDICAL OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
6,966 |
| 2025-03-14 | Holmlin R. Erik |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 198 shares of common stock in connection with shares that vested on March 14, 2025 pursuant to an PSU award granted on May 12, 2021, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the PSU award. |
Common Stock
|
198 |
| 2025-03-14 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date. |
Stock Option (Right to Buy)
|
6,966 |
| 2025-02-15 | Dixon Jonathan V. |
GENERAL COUNSEL |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 6 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 17,725 less shares of common stock. |
Common Stock
|
6 |
| 2025-02-15 | Adamchak Mark |
Principal Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 4 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 16,197 less shares of common stock. |
Common Stock
|
4 |
| 2025-02-15 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 20 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 60,262 less shares of common stock. |
Common Stock
|
20 |
| 2025-02-15 | Holmlin R. Erik |
Director, PRESIDENT AND CEO |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 51 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 120,428 less shares of common stock (119,934 less shares held directly and 494 less shares held indirectly). Includes 2 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024 (As adjusted for the January 2025 Reverse Stock Split). |
Common Stock
|
51 |
| 2025-02-15 | Chaubey Alka |
CHIEF MEDICAL OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer of an aggregate of 18 shares of common stock in connection with shares that vested on February 15, 2025 pursuant to an RSU award granted on February 15, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. On January 24, 2025, the common stock of Bionano Genomics, Inc. split 1-for-60, resulting in the reporting person's ownership of 44,568 less shares of common stock. |
Common Stock
|
18 |
| 2024-10-01 | Adamchak Mark |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% of the shares subject to the option vest on the one-year anniversary of the grant date. |
Stock Option (Right to Buy)
|
17,500 |
| 2024-09-11 | OLDAKOWSKI MARK |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
The reporting person is reporting the withholding by the Issuer an aggregate of 3,568 shares of common stock that vested on September 11, 2024, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award. Includes 153 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan on June 10, 2024. |
Common Stock
|
3,568 |